Facing antimicrobial resistance in cancer care: what the AIOM survey tells us about oncologists' awareness
- PMID: 40831750
- PMCID: PMC12359028
- DOI: 10.1093/jacamr/dlaf150
Facing antimicrobial resistance in cancer care: what the AIOM survey tells us about oncologists' awareness
Abstract
Background: Infections with antimicrobial-resistant (AMR) organisms significantly worsen outcomes in cancer patients. Since the main cause of AMR is the inappropriate use of antibiotics for prophylactic or empirical treatment, antimicrobial stewardship programmes (ASPs) have been developed. Few papers on ASPs describe prospective audits in oncology settings. In light of this, the Italian Association of Medical Oncology (AIOM) has decided to evaluate the oncologists' perceptions of this issue with a brief survey.
Methods: An anonymous 14-item questionnaire was shared online during the XXVI National Congress on the AIOM website. The survey was divided into two sections. The first set of questions collected the hospital organization and practices (Q1-Q6), while the second one was about the clinical practices and antibiotic therapy (Q7-Q14).
Results: Sixty-four medical oncologists completed the anonymous questionnaire. Seventy-two percent of respondents believe that AMR is a significant issue in cancer patients, and an equal percentage considers it likely that a cancer patient will become infected with a MDR pathogen. Despite these concerns, only 48% (n = 31/64) report having an active ASP in their centre. Just 6% of respondents (n = 4/64) consider themselves very confident in prescribing antibiotic therapy, while most consider themselves fairly or not very confident (n = 34/64, 53%, and n = 26/64, 36%, respectively).
Conclusions: This survey highlights the urgent need for educating and training oncologists on AMR, as well as the importance of the development of oncology-specific guidelines to mitigate the impact of AMR in this high-risk population.
© The Author(s) 2025. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
-
Ophthalmia Neonatorum.2025 Jul 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31855399 Free Books & Documents.
References
-
- Shelke A, Priya P, Mishra S et al. Investigation of antimicrobial susceptibility patterns, risk factors and their impact on mortality in cancer patients at a tertiary care cancer hospital—a prospective study. Ann Clin Microbiol Antimicrob 2024; 23: 59. 10.1186/s12941-024-00703-5 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources